Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: Is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA?

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 1129-1131

  Kayacelebi, Arslan Arinc ^a   Pham, Vu Vi ^a   Willers, Janina ^b   Hahn, Andreas ^b   Stichtenoth, Dirk O ^a   Jordan, Jens ^a   Tsikas, Dimitrios ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

ADMA; Cardiovascular disease; Homoarginine; Rheumatoid arthritis

Indexed keywords

ARGININE; BIOLOGICAL MARKER; HOMOARGININE; N,N-DIMETHYLARGININE;

ANALOGS AND DERIVATIVES; ARTHRITIS, RHEUMATOID; BLOOD; FEMALE; HUMAN; MALE;

ARGININE; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HOMOARGININE; HUMANS; MALE;

EID: 84908208988     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.296     Document Type: Article

References (21)

1. L. Lévy, B. Fautrel, T. Barnetche, and T. Schaeverbeke Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature Clin Exp Rheumatol 26 2008 673 679
2. C.S. Crowson, P.J. Nicola, and H.M. Kremers How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 52 2005 3039 3044
3. K. Wright, C.S. Crowson, and S.E. Gabriel Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure Heart Fail Clin 10 2014 339 352
4. J. Willers, and A. Hahn Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and of a German risk score model Rheumatol Int 32 2012 3741 3749
5. T. Dimitroulas, A. Sandoo, and G.D. Kitas Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases Int J Mol Sci 13 2012 12315 12335
6. A. Surdacki, J. Martens-Lobenhoffer, and A. Wloch Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis Arthritis Rheum 56 2007 809 819
7. T. Dimitroulas, A. Sandoo, and J.J. Veldhuijzen van Zanten Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance Scand J Rheumatol 42 2013 176 181
8. T. Dimitroulas, A. Sandoo, J.P. Smith, and G.D. Kitas Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis Int J Cardiol 172 2014 285 286
9. W. März, A. Meinitzer, and C. Drechsler Homoarginine, cardiovascular risk, and mortality Circulation 122 2010 967 975
10. D. Atzler, M. Rosenberg, and M. Anderssohn Homoarginine - an independent marker of mortality in heart failure Int J Cardiol 168 2013 4907 4909
11. C.U. Choe, D. Atzler, and P.S. Wild Homoarginine levels are regulated by l-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies Circulation 128 2013 1451 1461
12. A.A. Kayacelebi, T.H. Nguyen, C. Neil, J.D. Horowitz, J. Jordan, and D. Tsikas Homoarginine and 3-nitrotyrosine in patients with takotsubo cardiomyopathy Int J Cardiol 173 2014 546 547
13. D. Tsikas, and A.A. Kayacelebi Do homoarginine and asymmetric dimethylarginine act synergistically in opposite direction in the cardiovascular system? Circ J 78 2014 2094 2095
14. J. Willers, S. Fasse, and N. Putschky Combined add-on supplementation of omega-3 fatty acids, vitamin E, vitamin A, copper, and selenium in rheumatoid arthritis Food Nutr Sci 2 2011 714 723
15. A.A. Kayacelebi, B. Beckmann, F.M. Gutzki, J. Jordan, and D. Tsikas GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples Amino Acids 46 2014 2205 2217
16. D. Tsikas, B. Schubert, F.M. Gutzki, J. Sandmann, and J.C. Frölich Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative J Chromatogr B 798 2003 87 99
17. D. Tsikas Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/mass spectrometry Anal Chem 72 2000 4064 4072
18. D. Tsikas, A. Wolf, A. Mitschke, F.M. Gutzki, W. Will, and M. Bader GC-MS determination of creatinine in human biological fluids as pentafluorobenzyl derivative in clinical studies and biomonitoring: inter-laboratory comparison in urine with Jaffé, HPLC and enzymatic assays J Chromatogr B 878 2010 2582 2592
19. D. Tsikas, E. Schwedhelm, and M.T. Suchy Divergence in urinary 8-iso-PGF(2alpha) (iPF(2alpha)-III, 15-F(2t)-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF(2alpha). Possible methodological, mechanistic and clinical implications J Chromatogr B 794 2003 237 255
20. D. Tsikas, F.M. Gutzki, and D.O. Stichtenoth Circulating and excretory nitrite and nitrate as indicators of nitric oxide synthesis in humans: methods of analysis Eur J Clin Pharmacol 62 Suppl. 13 2006 51 59
21. E. Schwedhelm, R.A. Benndorf, R.H. Böger, and D. Tsikas Mass spectrometric analysis of F2-isoprostanes: markers and mediators in human disease Curr Pharm Anal 3 2007 39 51